Browse By: Country ι Category ι Latest Reports ι Tag
Home  »  GBI Research

GBI Research Market Research Reports

GBI Research provides industry-leading global business intelligence solutions. Our products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports per annum across a wide range of industries. Our reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from our expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia. Key report types currently published by GBI Research include:

  • Market Intelligence Reports: premium analytical reports based on a combination of market data, company, deals and project content, industry surveys and additional primary and secondary research.
  • Benchmarking Reports: analytical reports comparing key financial indicators for the top 20 companies in a particular industry and geography.
  • Industry Outlook Reports: survey-based reports, revealing and analyzing the leading experts' opinions on the future of the industry covered.
  • Market Profiles: overview-level reports based on market, company and demographic data.
  • Pipeline Analysis Reports: reports analyzing the unmet need, market size and product pipeline for different disease indications, based on a detailed database of developmental products.



MRI Systems Market to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies
GBI Researchs report, "MRI Systems Market to 2020 Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies" discusses the market, competitive landscape, and trends for three MRI systems market segments: High-field, Mid-field, and Low-field MRI systems. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the dynamics of the market. The report also reviews the competitive landscape, analyzes each segments pipeline products and gives details of important merger and acquisition deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts. Scope The report analyzes the MRI syst
Published Date: Apr 2015
Published By: GBI Research

Price: $3500
Market Digest: Multiparameter Patient Monitoring Devices 2006 to 2020 - Asia-Pacific
GBI Researchs report, "Market Digest: Multiparameter Patient Monitoring Devices 2006 to 2020 Asia-Pacific" provides quantitative analysis of the four multiparameter patient monitoring devices market segments: high acuity monitors, mid acuity monitors, low acuity monitors and multiparameter central stations. The analysis includes market size data by revenue and volume over the 20062020 period for the following countries: Australia, Japan, China and India. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts. Scope Information on market size for the four multiparameter patient monitoring devices market segments: high acuity monitors, mid acuity monitors, low acuity monitors
Published Date: Apr 2015
Published By: GBI Research

Price: $1750
Market Digest: Ultrasound Systems Market 2006 to 2020 - Americas
GBI Research’s report, ""Market Digest: Ultrasound Systems Market 2006 to 2020 Americas"" provides quantitative analysis of the two ultrasound systems market segments: stand-alone systems and portable systems. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: US, Brazil and Canada. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope The report includes  Information on market size for the two ultrasound systems market segments: stand-alone systems and portable systems. Annualized sales data by revenue for the 2006–2020 period Annualized sales data by volume for the 2
Published Date: Mar 2015
Published By: GBI Research

Price: $1750
Market Digest: Ultrasound Systems Market 2006 to 2020 - Asia-Pacific
GBI Researchs report, "Market Digest: Ultrasound Systems Market 2006 to 2020 Asia-Pacific" provides quantitative analysis of the two ultrasound systems market segments: stand-alone systems and portable systems. The analysis includes market size data by revenue and volume over the 20062020 period for the following countries: China, Japan, India and Australia. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts. Scope The report includes  Information on market size for the two ultrasound systems market segments: stand-alone systems and portable systems. Annualized sales data by revenue for the 20062020 period Annualized sales data by volume for the 20062020 period
Published Date: Mar 2015
Published By: GBI Research

Price: $1750
Market Digest: Ultrasound Systems Market 2006 to 2020 - Europe
GBI Researchs report, "Market Digest: Ultrasound Systems Market 2006 to 2020 Europe" provides quantitative analysis of the two ultrasound systems market segments: stand-alone systems and portable systems. The analysis includes market size data by revenue and volume over the 20062020 period for the following countries: Germany, France, UK, Italy and Spain. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts Scope The report includes  Information on market size for the two ultrasound systems market segments: stand-alone systems and portable systems. Annualized sales data by revenue for the 20062020 period Annualized sales data by volume for the 20062020 period Co
Published Date: Mar 2015
Published By: GBI Research

Price: $1750
Asthma Therapeutics in Major Developed Markets to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations
GBI Research, a leading business intelligence provider, has released its latest research report,""Asthma Therapeutics in Major Developed Markets to 2020  Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations"".The asthma therapeutics market is forecast to grow marginally over the forecast period across the top eight developed nations, from $18.4 billion in 2013 to a projected value of $21.7 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 2.4%. This is in spite of generic erosion facing several of the leading asthma brands, such as Advair (fluticasone propionate/salmeterol xinafoate), Symbicort (budesonide/formoterol fumarate) and Xolair (omalizumab), and is a consequence of new market entrants and rising disease prevalence. The glob
Published Date: Feb 2015
Published By: GBI Research

Price: $4995
Asthma Therapeutics Market to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations
GBI Research, a leading business intelligence provider, has released its latest research report: “Asthma Therapeutics Market to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations.” The asthma therapeutics market is forecast to grow marginally over the forecast period across the top eight developed nations, from $18.4 billion in 2013 to a projected value of $21.7 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 2.4%. This is in spite of generic erosion facing several of the leading asthma brands, such as Advair (fluticasone propionate/salmeterol xinafoate), Symbicort (budesonide/formoterol fumarate) and Xolair (omalizumab), and is a consequence of new market entrants and rising disease prevalence. The global preval
Published Date: Feb 2015
Published By: GBI Research

Price: $6995
Frontier Pharma: Pain - Identifying and Commercializing First-in-Class Innovation
Large and Innovative Pipeline The active pain pipeline is populated by 796 products across all stages of development, which exhibit a highly diverse range of molecular targets. GBI Research’s analyses identified 122 first-in-class programs in active development, constituting 13.6% of the pipeline and acting on 65 first-in-class molecular targets, indicating a high degree of innovation. This is in stark contrast to the pain therapeutics market, which has been largely characterized by only incremental product innovation over the last decade, as most market segments continue to be dominated by long-established active pharmaceutical ingredients and the concomitant mechanisms of action. Moderate-to-severe pain continues to be dominated by opioids that are increasingly being reformula
Published Date: Feb 2015
Published By: GBI Research

Price: $6995
Market Digest: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Americas
GBI Researchs report, "Market Digest: Aesthetic Lasers and Energy Devices Market 2006 to 2020 Americas" provides quantitative analysis of the three aesthetic lasers and energy devices market segments: minimally invasive body contouring devices, non-invasive body contouring devices and laser resurfacing devices. The analysis includes market size data by revenue and volume over the 20062020 period for the following countries: US, Brazil, Mexico and Canada. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts. Scope Information on market size for the three aesthetic lasers and energy devices market segments: minimally invasive body contouring devices, non-invasive body contou
Published Date: Feb 2015
Published By: GBI Research

Price: $1750
Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation
Large and Diverse Pipeline The liver cancer pipeline contains 238 products in active development, approximately 47% of which are first-in-class. The percentage of the pipeline devoted to innovative products is considerably larger than both the industry and oncology average, which is a promising sign for novel therapeutics reaching the liver cancer market. The contrast between the market and pipeline is vast. Analysis showed that the market contains 70 products, the majority of which are generic formulations of chemotherapies that are not frequently used in treatment, particularly in advanced-stage patients. Nexavar (sorafenib) is the dominant therapeutic on the market, and is also the only targeted therapy that is in regular use for advanced-stage liver cancer patients. However, pi
Published Date: Jan 2015
Published By: GBI Research

Price: $6995
Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches
GBI Research, a leading business intelligence provider, has released its latest research report: “Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches”. The report provides estimates of the market size for 2013, along with forecasts until 2020 for the Asia-Pacific markets of India, China, Australia and Japan. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of clinical trials including failure rates and pipeline analysis, and analysis of deals relevant to Ovarian Cancer (OC). Platinum-based chemotherapy, predominantly the chemotherapy regimen paclitaxel and carboplatin, is the standard of care for the treatment of platinum-sensitive OC (both first-lin
Published Date: Jan 2015
Published By: GBI Research

Price: $4995
Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics
GBI Research, the leading business intelligence provider, has released its latest research: “Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics”, which provides in-depth analysis of the Colorectal Cancer (CRC) therapeutics market in the eight major geographies of the US, Canada, the UK, France, Germany, Spain, Italy and Japan. The report provides an estimation of the market size for 2013, along with market forecast until 2020. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth pipeline analysis, and deal analysis. The CRC therapeutics market in the eight major markets is expected to grow at a Compound Annual Growth Rate (CAGR) of 1.8% to $9.4 billion b
Published Date: Jan 2015
Published By: GBI Research

Price: $4995
Market Digest: Multiparameter Patient Monitoring Devices 2006 to 2020 - Europe (Germany, France, Italy, UK and Spain)
GBI Research’s report, ""Market Digest: Multiparameter Patient Monitoring Devices 2006 to 2020 Europe (Germany, France, Italy, UK and Spain)” provides quantitative analysis of the four multiparameter patient monitoring devices market segments: high acuity monitors, mid acuity monitors, low acuity monitors and multiparameter central stations. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: Germany, France, UK, Italy and Spain. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Information on market size for the four multiparameter patient monitoring devices market segments: h
Published Date: Dec 2014
Published By: GBI Research

Price: $1750
Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth
GBI Research, the leading business intelligence provider, has released its latest research, “Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 Increasing Uptake of Novel Drug Classes to Drive Market Growth”, which provides insights into type 2 diabetes in the Asia-Pacific (APAC) markets of China, India, Japan and Australia. The report estimates the market size for 2013 and provides a forecast until 2020, and covers disease epidemiology, treatment algorithms, and treatment use patterns. It also provides in-depth analysis of the pipeline molecules, clinical trial failure rates, and recent deals. The report has been built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis carried out by GBI Research&rsqu
Published Date: Nov 2014
Published By: GBI Research

Price: $4995
Frontier Pharma: Parkinsons Disease - Identifying and Commercializing First-in-Class Innovation
Large Degree of Innovation in Parkinson’s Disease Pipeline The Parkinson’s disease (PD) pipeline currently has 302 products in active development across all stages, but a stark contrast between the mechanisms of action employed in the current market and the pipeline is evident. Where the market relies on symptomatic treatments that target neuromodulatory receptors, the pipeline shows a diverse range of neuroprotective therapies targeting dysfunctional disease processes. This diversity is partially due to the presence of 90 first-in-class products, which accounts for 37% of the overall pipeline therapies that disclosed their target. In an industry, market and development landscape that favors first-in-class over non-first-in-class development in many ways, such as through f
Published Date: Nov 2014
Published By: GBI Research

Price: $6995
Market Snapshot: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Asia-Pacific
GBI Research’s report, “Market Snapshot: Aesthetic Lasers and Energy Devices Market 2006 to 2020 Asia-Pacific” provides quantitative analysis of the three aesthetic lasers and energy devices market segments: minimally invasive body contouring devices, non-invasive body contouring devices and laser resurfacing devices. The analysis includes market size data by revenue and volume over the 2006 2020 period for the following countries: China, Japan, South Korea, Australia and India. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Information on market size for the three aesthetic lasers and energy devices market segments: minimally invasive b
Published Date: Nov 2014
Published By: GBI Research

Price: $1750
Market Digest: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Asia-Pacific
GBI Research’s report, “Market Digest: Aesthetic Lasers and Energy Devices Market 2006 to 2020 Asia-Pacific” provides quantitative analysis of the three aesthetic lasers and energy devices market segments: minimally invasive body contouring devices, non-invasive body contouring devices and laser resurfacing devices. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: Australia, China, India, Japan and South Korea. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Information on market size for the three aesthetic lasers and energy devices market segments:  minim
Published Date: Nov 2014
Published By: GBI Research

Price: $1750
Frontier Pharma - NSCLC - Identifying and Commercializing First-in-Class Innovation in Non-Small-Cell Lung Carcinoma
Large Degree of Innovation in NSCLC Pipeline The NSCLC pipeline currently has 389 products in active development across all stages, but a stark contrast between the mechanisms of action employed in the current market and the pipeline is evident. Where the market comprises primarily ineffective chemotherapies that target tubulin or DNA replication, the pipeline shows an incredibly diverse range of therapies targeting multiple signaling pathways and molecules integral to cancer development. This diversity is partially due to the presence of 122 first-in-class products, which accounts for 38% of the overall pipeline therapies that disclosed their target. In an industry, market and development landscape that favors first-in-class over non-first-in-class development in many ways, such as thr
Published Date: Oct 2014
Published By: GBI Research

Price: $6995
Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies
GBI Research, the leading business intelligence provider, has released its latest research: ‘Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies ’, which provides in-depth insights into the indication. It gives an estimation of market size for 2013 along with forecasts until 2020 for the Asia-Pacific (APAC) region, which comprises Australia, China, India and Japan.  It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of clinical trials including failure rates and pipeline analysis, and analysis of deals relevant to Colorectal Cancer (CRC). The market in the APAC region was worth an estimated $1.9 billion in 2013 and is expected to
Published Date: Oct 2014
Published By: GBI Research

Price: $4995
Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options
GBI Research, a leading business intelligence provider, has released its latest research report: “Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options”, which provides in-depth insight into the indication. It provides estimates of market size for 2013 along with forecasts until 2020 for the eight major developed markets, which comprises the US, UK, France, Germany, Italy, Spain, Japan and Canada. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of clinical trials including failure rates and pipeline analysis, and analysis of deals relevant to Non-Hodgkin Lymphoma (NHL). The value of the NHL market is expected to reach $9
Published Date: Oct 2014
Published By: GBI Research

Price: $4995
Market Snapshot: Cardiac Rhythm Management Devices 2006 to 2020 - US and Europe (US, Germany, France, Italy, UK, Spain)
GBI Research’s report, “Market Snapshot: Cardiac Rhythm Management Devices 2006 to 2020 US and Europe (US, Germany, France, Italy, UK, Spain)” provides quantitative analysis of the four cardiac rhythm management devices market segments: : cardiac resynchronization therapy devices, implantable cardioverter defibrillators, implantable loop recorders and pacemakers. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: US, Germany, France, Italy, UK and Spain. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Information on market size for the four cardiac rhythm management de
Published Date: Oct 2014
Published By: GBI Research

Price: $1750
Market Digest: Cardiac Rhythm Management Devices 2006 to 2020 - US and Europe (US, Germany, France, Italy, UK, Spain)
GBI Research’s report, “Market Digest: Cardiac Rhythm Management Devices 2006 to 2020 US and Europe (US, Germany, France, Italy, UK, Spain)” provides quantitative analysis of the four cardiac rhythm management devices market segments: : cardiac resynchronization therapy devices, implantable cardioverter defibrillators, implantable loop recorders and pacemakers. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: US, Germany, France, Italy, UK and Spain. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Information on market size for the four cardiac rhythm management device
Published Date: Oct 2014
Published By: GBI Research

Price: $1750
Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries
GBI Research, the leading business intelligence provider, has released its latest research, ‘Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries’, which provides insights into Major Depressive Disorder (MDD) in the major developed markets of the US, the UK, France, Germany, Italy, Spain, Japan and Canada. The report provides an estimation of market size for 2013, along with market forecast until 2020. It also covers disease epidemiology, treatment algorithms, treatment use patterns, in-depth analysis of the pipeline, clinical trial failure rate and deal analysis for MDD. The report is built using data and information sourced from proprietary databases, primary and secon
Published Date: Oct 2014
Published By: GBI Research

Price: $4995
Market Digest: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Europe (Germany, France, Italy, UK, Spain)
The report covers the Europe (Germany, France, Italy, UK and Spain) aesthetic lasers and energy devices market revenue and volume for the following segments: Minimally Invasive Body Contouring (MIBC) Devices, Non-Invasive Body Contouring (NIBC) Devices and Laser Resurfacing (LR) Devices. The report also provides company shares by revenue for the above mentioned countries for the year 2013. Scope Information on market size for the three aesthetic lasers and energy devices market segments: minimally invasive body contouring devices, non-invasive body contouring devices and laser resurfacing devices. Annualized sales data by revenue for the 2006–2020 period and company share data by revenue for 2013 Annualized sales data by volume for the 2006–2020 period Coverage o
Published Date: Oct 2014
Published By: GBI Research

Price: $1750
Market Snapshot: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Europe (Germany, France, Italy, UK, Spain)
GBI Research’s report, “Market Snapshot: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Europe (Germany, France, Italy, UK, Spain)” provides quantitative analysis of the three aesthetic lasers and energy devices market segments: minimally invasive body contouring devices, non-invasive body contouring devices and laser resurfacing devices. The analysis includes market size data by revenue and volume over the 2006-2020 period for the following countries: Germany, France, Italy, UK and Spain. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.  Scope Information on market size for the three aesthetic lasers and energy devices market segm
Published Date: Oct 2014
Published By: GBI Research

Price: $1750
Picture Archiving and Communication Systems Market to 2020 - Digitization of Healthcare Systems and Evolution of PACS as a Decision Support Tool Drive Growth
GBI Research’s report, “Picture Archiving and Communication Systems Market to 2020 - Digitization of Healthcare Systems and Evolution of PACS as a Decision Support Tool Drive Growth” discusses the market, competitive landscape, and trends for two Picture Archiving and Communications Systems (PACS) market segments: radiology PACS and cardiology PACS. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the dynamics of the overall market. The report also reviews the competitive landscape, analyzes pipeline products by segment and gives details of important Merger and Acquisition (M&A) deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house ana
Published Date: Oct 2014
Published By: GBI Research

Price: $3500
Melanoma Therapeutics Market to 2020 - Rising Prevalence and Evolving Treatment Algorithms to Drive Market Growth
GBI Research, a leading business intelligence provider, has released its latest research report “Melanoma Therapeutics Market to 2020 - Rising Prevalence and Evolving Treatment Algorithms to Drive Market Growth.” Melanoma is a highly heterogeneous disease comprising Cutaneous Melanoma (CM), Ocular Melanoma (OM), Mucosal Melanoma (MM), melanoma of the internal organs, and, according to some classifications, melanoma of the soft parts (non-bony and non-cartilaginous tissues) of the body. CM is by far the most common form of melanoma, accounting for approximately 90–95% of all melanomas. Historically, melanoma has been considered as a very challenging disease to treat with pharmacotherapy. However, in recent years, understanding of the pathophysiology and heterogeneity
Published Date: Sep 2014
Published By: GBI Research

Price: $4995
Acute Myeloid Leukemia Therapeutics Market to 2020 - Novel Therapies to Offer Clinical Benefit in Small Patient Cohorts
GBI Research, has released its latest pharma report - “Acute Myeloid Leukemia Therapeutics Market to 2020: Novel Therapies to Offer Clinical Benefit in Small Patient Cohorts’. Treatment and prognosis in AML is strongly influenced by a patient’s age, and their cytogenetic profile. In the majority of cases these two prognostic influences are linked, with a higher frequency of unfavorable cytogenetic abnormalities observed in the elderly. Survival in this cohort of elderly patients is very poor, with a five year overall survival of 3–8% (Luger, 2010). Despite a relatively advanced understanding of genetic abnormalities associated with AML, the introduction of targeted therapies is lagging in this indication in comparison to other cancers such as breast and lung canc
Published Date: Sep 2014
Published By: GBI Research

Price: $4995
Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting
GBI Research, the leading business intelligence provider, has released its latest research: ‘Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting ’, which provides in-depth insights into the indication. It gives an estimation of market size for 2013 along with forecasts until 2020 for the Asia-Pacific (APAC) region, which comprises Australia, China, India and Japan. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of clinical trials including failure rates and pipeline analysis, and analysis of deals relevant to Non-Hodgkin Lymphoma (NHL). The market in the APAC region was worth an estimated $1.1 billion in 2013 and is expected to grow at a
Published Date: Sep 2014
Published By: GBI Research

Price: $4995
Market Snapshot: Mammography Systems 2006 to 2020 - Americas (US, Canada, Brazil, Mexico)
GBI Research’s report, “Market Snapshot: Mammography Systems 2006 to 2020 Americas (US, Canada, Brazil, Mexico)” provides quantitative analysis of the two mammography systems market segments: full field mammography systems and film-screen mammography systems. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: the US, Canada, Brazil and Mexico It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Information on market size for the two mammography systems market segments: full field mammography systems and film-screen mammography systems Annualized sales data by revenue for
Published Date: Sep 2014
Published By: GBI Research

Price: $1750
Market Digest: Mammography Systems 2006 to 2020 - Americas (US, Canada, Brazil, Mexico)
GBI Research’s report, “Market Digest: Mammography Systems 2006 to 2020 Americas (US, Canada, Brazil, Mexico)” provides quantitative analysis of the two mammography systems market segments: full field mammography systems and film-screen mammography systems. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: the US, Canada, Brazil and Mexico It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Information on market size for the two mammography systems market segments: full field mammography systems and film-screen mammography systems Annualized sales data by revenue for t
Published Date: Sep 2014
Published By: GBI Research

Price: $1750
Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM
GBI Research, the leading business intelligence provider, has released its latest research: ‘Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM’, which provides in-depth analysis of the Glioblastoma Multiforme (GBM) therapeutics market within the Asia-Pacific (APAC) region, covering Australia, China, India and Japan. The report provides estimates of market size for 2013, along with market forecasts until 2020. It also covers disease epidemiology, treatment algorithms, treatment patterns, and in-depth analysis of the marketed and pipeline products. The value of the GBM market in the APAC region amounted to an estimated $49.4m in 2013, and is expected to register a Compoun
Published Date: Aug 2014
Published By: GBI Research

Price: $3500
Market Digest: Transcatheter Heart Valve 2007 to 2020 - Europe (Germany, France, Italy, UK, Spain)
GBI Research’s report, “Market Digest: Transcatheter Heart Valve 2007 to 2020 Europe (Germany, France, Italy, UK, Spain)” provides quantitative analysis of the transcatheter heart valves market in Europe. The analysis includes market size data by revenue and volume over the 2007–2020 period and key company share data by revenue in 2013 for the following countries: Germany, France, Italy, UK, Spain. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Information on market size for the transcatheter heart valves Annualized sales data by revenue for the 2007–2020 period and company share data by revenue for 2013 Annualized sales
Published Date: Aug 2014
Published By: GBI Research

Price: $1750
Market Snapshot: Transcatheter Heart Valve 2007 to 2020 - Europe
GBI Research’s report: “Transcatheter Heart Valve 2007 to 2020 – Europe” provides quantitative analysis of the transcatheter heart valves market in Europe. The analysis includes market size data by revenue and volume over the 2007–2020 period and key company share data by revenue in 2013 for the following countries: Germany, France, Italy, UK, Spain. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Information on market size for the transcatheter heart valves Annualized sales data by revenue for the 2007–2020 period and company share data by revenue for 2013 Annualized sales data by volume for the 2007–2020 period
Published Date: Aug 2014
Published By: GBI Research

Price: $1750
Ventilators Market to 2020 - Technical Advances and Hospital Expansion Serve as Distinct Regional Growth Drivers
Ventilators Market to 2020” discusses the market, competitive landscape, and trends for three ventilator market segments: Adult/pediatric, neonatal and transport ventilators. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the dynamics of the market. The report also reviews the competitive landscape, analyzes pipeline products by segment and gives details of important merger and acquisition deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Key geographies: US, Canada, Brazil, UK, Germany, France, Italy, Spain, Japan, China, India and Australia Information on market size f
Published Date: Aug 2014
Published By: GBI Research

Price: $3500
Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market
GBI Research, a leading business intelligence provider, has released its latest research report, “Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market”. The value of the Non-Small Cell Lung Cancer (NSCLC) market is expected to increase significantly over the forecast period across the leading eight developed nations, from $5.1 billion in 2013 to $7.9 billion in 2020. This equates to a Compound Annual Growth Rate (CAGR) of 6.6%. Growth will be driven by novel therapies entering the squamous cell carcinoma market segment, which is currently lacking effective treatment, unlike the non-squamous market segment. The report focuses on the increasing differentiation between the three ma
Published Date: Jul 2014
Published By: GBI Research

Price: $3500
Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation
Exceptionally Large and Innovative Pipeline The breast cancer pipeline is the largest in the pharmaceutical industry with 815 products in active development across all stages. The range of mechanisms of action employed by these compounds is also highly diverse, especially in comparison to the existing market landscape. More pertinently, the degree and proportion of breakthrough innovations in this pipeline is exceptional; GBI Research analysis identified 253 first-in-class programs in the breast cancer pipeline, acting on 176 first-in-class molecular targets. This accounts for some 39% of all products with a disclosed molecular target and is reflective of the high degree of innovation in this indication. This has far-reaching strategic implications for all market participants, as, des
Published Date: Jul 2014
Published By: GBI Research

Price: $6995
Market Digest: Transcatheter Heart Valves 2007 to 2020 - Americas (US, Canada, Brazil, Mexico)
GBI Research’s report, “Market Digest: Transcatheter Heart Valves 2007 to 2020 Americas (US, Canada, Brazil, Mexico)” provides quantitative analysis of the transcatheter heart valves market in Americas. The analysis includes market size data by revenue and volume over the 2007–2020 period and key company share data by revenue in 2013 for the following countries: US, Canada, Brazil and Mexico. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Information on market size for the transcatheter heart valves Annualized sales data by revenue for the 2007–2020 period and company share data by revenue for 2013 Annualized sales data b
Published Date: Jul 2014
Published By: GBI Research

Price: $1750
Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market
GBI Research, the leading business intelligence provider, has released its latest research: “Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market”, which provides in-depth analysis of the critical care market in the US, UK, France, Germany, Italy, Spain, Japan and Canada. The report provides an estimation of market size for 2013, along with market forecasts to 2020. It covers critical care indications that are being treated using the five major plasma-derived products of albumin, anti-thrombin concentrates, factor XIII concentrates, fibrinogen concentrates, and prothrombin complex concentrates. The total value of the critical care market in the major developed markets was estimated at $1.8 b
Published Date: Jul 2014
Published By: GBI Research

Price: $3500
Market Snapshot: Transcatheter Heart Valves 2007 to 2020 - Americas
GBI Research’s report: “Transcatheter Heart Valves 2007 to 2020 – Americas” provides quantitative analysis of the transcatheter heart valves market in Americas. The analysis includes market size data by revenue and volume over the 2007–2020 period and key company share data by revenue in 2013 for the following countries: US, Canada, Brazil and Mexico. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Information on market size for the transcatheter heart valves Annualized sales data by revenue for the 2007–2020 period and company share data by revenue for 2013 Annualized sales data by volume for the 2007–2020 per
Published Date: Jul 2014
Published By: GBI Research

Price: $1750
Market Snapshot: Mammography Systems 2006 to 2020 - Europe (Germany, UK, France, Italy, Spain)
GBI Research’s report, “Market Snapshot: Mammography Systems 2006 to 2020 - Europe (Germany, UK, France, Italy, Spain)” provides quantitative analysis of the two mammography systems market segments: full field mammography systems and film-screen mammography systems. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: Germany, UK, France, Italy and Spain. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Information on market size for the two mammography systems market segments: full field mammography systems and film-screen mammography systems Annualized sales data b
Published Date: Jul 2014
Published By: GBI Research

Price: $1750
Market Digest: Mammography Systems 2006 to 2020 - Europe (Germany, UK, France, Italy, Spain)
GBI Research’s report, “Market Digest: Mammography Systems 2006 to 2020 Europe (Germany, UK, France, Italy, Spain)” provides quantitative analysis of the two mammography systems market segments: full field mammography systems and film-screen mammography systems. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: Germany, UK, France, Italy and Spain. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Information on market size for the two mammography systems market segments: full field mammography systems and film-screen mammography systems Annualized sales data by reve
Published Date: Jul 2014
Published By: GBI Research

Price: $1750
Market Snapshot: Glucose Monitoring Devices 2006 to 2020 - Benelux and Scandinavia (Netherlands, Belgium, Luxembourg, Sweden, Denmark and Norway)
GBI Research’s report, ""Market Digest: Glucose Monitoring Devices 2006 to 2020 Benelux and Scandinavia (Netherlands, Belgium, Luxembourg, Sweden, Denmark and Norway)” provides quantitative analysis of the two glucose monitoring devices market segments: blood glucose meters and blood glucose test strips. The analysis includes market size data by revenue and volume over the 2006–2020 period and key company share data by revenue and volume in 2013 for the following countries: are Netherlands, Belgium, Luxembourg, Sweden, Denmark and Norway. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Information on market size for the two glucose moni
Published Date: Jun 2014
Published By: GBI Research

Price: $1750
Market Digest: Mammography Systems 2006 to 2020 - Asia-Pacific (China, Japan, South Korea, Australia, India)
GBI Research’s report, “Market Digest: Mammography Systems 2006 to 2020 Asia-Pacific (China, Japan, South Korea, Australia, India)” provides quantitative analysis of the two mammography systems market segments: full field mammography systems and film-screen mammography systems. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: China, Japan, South Korea, Australia and India. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Information on market size for the two mammography systems market segments: full field mammography systems and film-screen mammography systems
Published Date: Jun 2014
Published By: GBI Research

Price: $1750
Market Snapshot: Glucose Monitoring Devices 2006 to 2020 - Benelux and Scandinavia (Netherlands, Belgium, Luxembourg, Sweden, Denmark and Norway)
Market Snapshot: Glucose Monitoring Devices 2006 to 2020 Benelux and Scandinavia (Netherlands, Belgium, Luxembourg, Sweden, Denmark and Norway)” provides quantitative analysis of the two glucose monitoring devices market segments: blood glucose meters and blood glucose test strips. The analysis includes market size data by revenue and volume over the 2006–2020 period and key company share data by revenue and volume in 2013 for the following countries: are Netherlands, Belgium, Luxembourg, Sweden, Denmark and Norway. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Information on market size for the two glucose monitoring devices market segments:
Published Date: Jun 2014
Published By: GBI Research

Price: $1750
Market Snapshot: Mammography Systems 2006 to 2020 - Asia-Pacific
Mammography Systems 2006 to 2020 – Asia-Pacific provides quantitative analysis of the two mammography systems market segments: full field mammography systems and film-screen mammography systems. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: China, Japan, South Korea, Australia and India. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Information on market size for the two mammography systems market segments: full field mammography systems and film-screen mammography systems Annualized sales data by revenue for the 2006–2020 period and company share data by revenue f
Published Date: Jun 2014
Published By: GBI Research

Price: $1750
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany
GBI Research, a leading business intelligence provider, has released its latest research report: “Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany”. Due to the poor prognosis under currently available treatments, therapies with high potency are in strong demand in the Glioblastoma Multiforme (GBM) market. In newly diagnosed patients, the current standard of care, comprising resection surgery, radiation therapy and chemotherapy with Merck’s Temodar (temozolomide), has a maximum Overall Survival (OS) of 15 months and almost inevitable tumor recurrence. Current therapeutic options for recurrent GBM are Roche’s Avastin (bevacizumab), carmustine and other c
Published Date: Jun 2014
Published By: GBI Research

Price: $3500
Market Snapshot: Glucose Monitoring Devices 2014 - Benelux and Scandinavia
GBI Research’s report: “Glucose Monitoring Devices 2014 – Benelux and Scandinavia” provides quantitative analysis of the two glucose monitoring devices market segments: blood glucose meters and blood glucose test strips. The analysis includes market size data by revenue and volume over the 2006–2020 period and key company share data by revenue and volume in 2013 for the following countries: are Netherlands, Belgium, Luxembourg, Sweden, Denmark and Norway. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Information on market size for the two glucose monitoring devices market segments: blood glucose meters and blood glucose te
Published Date: Jun 2014
Published By: GBI Research

Price: $3500
Anti-Hypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries
GBI Research, the leading business intelligence provider, has released its latest research: ‘Anti-Hypertensive Therapeutics in Major Developed Markets to 2020 – Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries ’, which provides in-depth analysis of hypertension therapeutics market within the eight major geographies of the US, the top five European countries (the UK, France, Germany, Spain and Italy), Japan and Canada. The report provides an estimation of market size for 2013, along with market forecast until 2020. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis. The value of the hypertension market in the major developed markets amounted to an estimated $4
Published Date: Jun 2014
Published By: GBI Research

Price: $3500
Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs
GBI Research, the leading business intelligence provider, has released its latest research: ‘Breast Cancer Therapeutics in Major Developed Markets to 2020 – Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs ’, which provides in-depth analysis of breast cancer therapeutics market within the eight major geographies of the US, Canada, the top five geographies in Europe (the UK, France, Germany, Spain and Italy) and Japan. The report provides an estimation of market size for 2013, along with market forecast until 2020. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis. The breast cancer therapeutics market in the eight major markets – The US, The UK, Franc
Published Date: Jun 2014
Published By: GBI Research

Price: $3500
Market Snapshot: Glucose Monitoring Devices 2006 to 2020 - Southeast Asia (Taiwan, Indonesia, Malaysia, Singapore, Vietnam)
GBI Research’s report, ""Market Digest: Glucose Monitoring Devices 2006 to 2020 Southeast Asia (Taiwan, Indonesia, Malaysia, Singapore, Vietnam)” provides quantitative analysis of the two glucose monitoring devices market segments: blood glucose meters and blood glucose test strips. The analysis includes market size data by revenue and volume over the 2006–2020 period and key company share data by revenue and volume in 2013 for the following countries: Taiwan, Indonesia, Malaysia, Singapore and Vietnam. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Information on market size for the two glucose monitoring devices market segments: bloo
Published Date: May 2014
Published By: GBI Research

Price: $1750
Frontier Pharma: Psoriasis - Identifying and Commercializing First-in-Class Innovation
Psoriasis is a chronic, inflammatory disease triggered by deregulated Thymus-derived (T) cells, resulting inflammation and benign hyperplasia of keratinocytes within the skin. Manifestations of affected skin are red, thickened plaques with an overlying silver-white scale, which significantly impairs the patient’s physical and mental wellbeing. The primary cause of psoriasis is unknown, as are the mechanisms that lead to immune cells directing inflammatory responses towards the skin. Within the lucrative autoimmune market, the psoriasis market has grown considerably due to the repositioning of all three marketed Tumor Necrosis Factor (TNF) inhibitors: Humira (adalimumab) and Enbrel (etanercept) which were originally approved for rheumatoid arthritis, and also Remicade (infliximab), th
Published Date: May 2014
Published By: GBI Research

Price: $3500
Market Snapshot: Glucose Monitoring Devices 2014 - Southeast Asia
GBI Research’s report: "Market Snapshot: Glucose Monitoring Devices 2014 - Southeast Asia” provides quantitative analysis of the two glucose monitoring devices market segments: blood glucose meters and blood glucose test strips. The analysis includes market size data by revenue and volume over the 2006–2020 period and key company share data by revenue and volume in 2013 for the following countries: Taiwan, Indonesia, Malaysia, Singapore and Vietnam. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Information on market size for the two glucose monitoring devices market segments: blood glucose meters and blood glucose test strips Annualized
Published Date: May 2014
Published By: GBI Research

Price: $1750
Facial Aesthetics Market to 2020 - Economic Recovery Drives Growth in the US as Increasing Awareness Fuels Demand in Developing Markets
GBI Research’s report: “Facial Aesthetics Market to 2020 - Economic Recovery Drives Growth in the US as Increasing Awareness Fuels Demand in Developing Markets” discusses the market, competitive landscape, and trends for two facial aesthetics market segments: Botox and dermal fillers. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the dynamics of the market. The report also reviews the competitive landscape, analyzes each segment’s pipeline products and gives details of important merger and acquisition deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope
Published Date: May 2014
Published By: GBI Research

Price: $3500
Ovarian Cancer Therapeutics to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free Survival and Targeted Therapies
“Ovarian Cancer Therapeutics to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free Survival and Targeted Therapies”. The current Ovarian cancer therapeutics market is dominated by the use of generics – predominately carboplatin and paclitaxel, which are used in combination for the treatment of platinum-sensitive disease (both first-line and recurrent). Initial treatment with platinum-based therapy is usually effective, with approximately 70% of patients entering remission. However, even with extended progression free-survival of 24 months, almost all patients relapse, and after successive periods of remission and relapse either die or progress to platinum-resistant disease, for which the prognosis is poor. There is a clear gap in the market for maintenance th
Published Date: May 2014
Published By: GBI Research

Price: $3500
Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options
Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 – Novel HER-2 Positive Therapies Provide Diversified Treatment Options’, which provides in-depth analysis of breast cancer market within the Asia-Pacific (APAC) covering the four countries of Australia, China, India and Japan. The report provides an estimation of market size for 2013, along with market forecast until 2020. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis. The breast cancer therapeutics market in the four Asia-Pacific (APAC) countries of India, Australia, China and Japan was worth $1.5 billion in 2013 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.6% to $2.5 billion by 2020. Japan had the largest mark
Published Date: May 2014
Published By: GBI Research

Price: $3500
HIV Therapeutics in Major Developed Market to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth
The leading business intelligence provider GBI Research has released its latest research report, entitled “HIV Therapeutics Market to 2019 – Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth”. The report provides insights into the HIV (Human Immunodeficiency Virus) therapeutics market including market forecasts up to 2019. It provides an in-depth analysis of the major marketed products, as well as insights into the HIV therapeutics R&D pipeline. The report provides in-depth analysis of the unmet needs, drivers and barriers that affect the global HIV therapeutics market. The report analyzes the market for HIV therapeutics in eight major markets of the US, the top five countries in Europe (the UK, Ger
Published Date: Apr 2014
Published By: GBI Research

Price: $3500
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant’, which provides in-depth analysis of pancreatic adenocarcinoma market within the eight major developed markets of the US, UK, France, Germany, Italy, Spain, Japan and Canada. The report provides an estimation of the market size for 2012, along with market forecasts to 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis. The global pancreatic adenocarcinoma therapeutics market is expected to grow from approximately $856m in 2012 to $1.2 billion in 2019, with growth driven by small changes in multiple factors. These include the i
Published Date: Apr 2014
Published By: GBI Research

Price: $3500
HIV Therapeutics Market to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth
The leading business intelligence provider GBI Research has released its latest research report, entitled “HIV Therapeutics Market to 2019 – Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth”. The report provides insights into the HIV (Human Immunodeficiency Virus) therapeutics market including market forecasts up to 2019. It provides an in-depth analysis of the major marketed products, as well as insights into the HIV therapeutics R&D pipeline. The report provides in-depth analysis of the unmet needs, drivers and barriers that affect the global HIV therapeutics market. The report analyzes the market for HIV therapeutics in eight major markets of the US, the top five countries in Europe (the UK, Germa
Published Date: Apr 2014
Published By: GBI Research

Price: $3500
Pancreatic Adenocarcinoma Therapeutics Market in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant
GBI Research, the leading business intelligence provider, has released its latest research: ‘Pancreatic Adenocarcinoma Therapeutics Market in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant’, which provides in-depth analysis of pancreatic adenocarcinoma market within the eight major developed markets of the US, UK, France, Germany, Italy, Spain, Japan and Canada. The report provides an estimation of the market size for 2012, along with market forecasts to 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis. The global pancreatic adenocarcinoma therapeutics market is expected to grow from approximately $856m in 201
Published Date: Apr 2014
Published By: GBI Research

Price: $3500
Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers
GBI Research’s report: Insulin Delivery Devices Market to 2019 examines the market, competitive landscape, and trends for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment’s pipeline products and gives details of important mergers and acquisitions. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope The markets of 12 key geographies are covered: U
Published Date: Apr 2014
Published By: GBI Research

Price: $3500
Epilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs with Novel Mechanisms of Action Signal a Shift in Treatment Patterns
GBI Research has released its pharma research: ‘Epilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs with Novel Mechanisms of Action Signal a Shift in Treatment Patterns ’, which provides in-depth analysis of epilepsy market within the eight major developed markets of the US, UK, France, Germany, Italy, Spain, Japan and Canada. The report provides an estimation of the market size for 2012, along with market forecasts to 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis. The value of the epilepsy market in the major developed markets amounted to an estimated $3.4 billion in 2012 and is expected to register a Compound Annual Growth Rate (CAGR) of 3.9% to reach $4.5 billion by
Published Date: Mar 2014
Published By: GBI Research

Price: $3500
NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool
GBI Research, the leading business intelligence provider, has released its latest research: ‘NSCLC Therapeutics in APAC Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool’, which provides in-depth insights into the Non-Small Cell Lung Cancer (NSCLC) indication. The report provides an estimation of the market size for 2012 along with market forecasts until 2019 for the Asia-Pacific (APAC) region, covering Australia, China, India and Japan. It also covers disease epidemiology, treatment algorithms, treatment patterns, clinical trial analysis (including failure rates), pipeline analysis, and analysis of deals relevant to NSCLC. The NSCLC market in the APAC region is estimated to have been worth $1.8 billion in 2
Published Date: Mar 2014
Published By: GBI Research

Price: $3500
Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability
GBI Research, the leading business intelligence provider, has released its latest research: ‘Epilepsy Therapeutics to 2019 in Asia-Pacific Market’, which provides in-depth analysis of epilepsy market within the Asia-Pacific (APAC) market covering the four countries of Australia, China, India and Japan. The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis.  The value of the epilepsy market in the APAC region amounted to an estimated $1.1 billion in 2012 and is expected to register a Compound Annual Growth Rate (CAGR) of 4.7% to reach $1.5 billion by 2019. The key drivers for growth in the APAC mar
Published Date: Mar 2014
Published By: GBI Research

Price: $3500
Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive Towards Personalized Treatment and Market Growth
GBI Research has released its pharma report “Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive Towards Personalized Treatment and Market Growth.” The value of the Cystic Fibrosis (CF) market is expected to increase significantly in value over the forecast period across the leading eight developed nations, from $695.6 million in 2012 to almost $4.5 billion in 2019. This equates to a Compound Annual Growth Rate (CAGR) of 30.4%. Novel treatments with disease-modifying mechanisms of action are the primary factor driving the growth of the value of the market. The positive impact of new market entrants will offset the effects of key patent losses during the forecast period.  Cystic Fibrosis Transmembrane conductance Regulators
Published Date: Feb 2014
Published By: GBI Research

Price: $3500
Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth Description
GBI Research has released its pharma report “Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth”. The systemic psoriasis market is forecast to grow substantially over the forecast period from $5.0 billion in 2013 to $10.4 billion in 2020, across the eight major markets. This growth will be driven by a rising treatment population and the continued uptake of biologics. Biologics will continue to drive market growth despite leading brands Enbrel (etanercept), Humira (adalimumab) and Remicade (infliximab) losing patent protection in most of the major markets over the forecast period. Although the market will suffer revenue losses as a result of sales erosion from biosimilar competitors, this
Published Date: Feb 2014
Published By: GBI Research

Price: $3500
Glucose Monitoring Device Market to 2019 - Technology Adoption and Increasing Health Awareness Serve as Distinct Regional Growth Drivers
GBI Research’s report: “Glucose Monitoring Device Market to 2019 - Technology adoption and increasing health awareness serve as distinct regional growth drivers” looks at the market, competitive landscape, and trends for the three glucose monitoring devices market segments: blood glucose meters, blood glucose testing strips, and lancets. The report provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. It also reviews the competitive landscape and gives detailed analysis of each segment’s pipeline products, as well as details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Resear
Published Date: Feb 2014
Published By: GBI Research

Price: $3500
Hepatitis C Therapeutics in Major Developed Markets to 2019 - Outstanding Recent Approvals and Late-Stage Pipeline to Transform Clinical and Commercial Landscape
GBI Research, has released the pharma report – “Hepatitis C Therapeutics in Major Developed Markets to 2019 – Outstanding Recent Approvals and Late-Stage Pipeline to Transform Clinical and Commercial Landscape”. The current Hepatitis C treatment landscape consists of a combination of pegylated interferon, ribavirin and, in patients infected with genotype 1 hepatitis C, one of two direct-acting antiviral agents (DAAs). Products with these mechanisms of action have performed strongly in the commercial setting, with the market leader Incivek (a DAA) having reached blockbuster sales. However, these products are very poorly tolerated and only moderately efficacious. The approval of the DAA Sovaldi in December 2013 changed this, with a complete viral clearance being ach
Published Date: Jan 2014
Published By: GBI Research

Price: $3500
Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need
GBI Research, the leading business intelligence provider, has released its latest research, "Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 – Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need", which provides insights into three therapeutic indications in gastrointestinal disorders in Asia-Pacific (APAC) markets of India, China, Japan and Australia. The report provides an in-depth analysis of the therapeutic indications of gastrointestinal disorders, namely Irritable Bowel Syndrome (IBS), Ulcerative Colitis (UC) and Crohn’s Disease (CD). The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis o
Published Date: Jan 2014
Published By: GBI Research

Price: $3500
Gastrointestinal Therapeutics in Major Developed Markets to 2019 - New Drug Approvals and Promising Pipeline to Counter Declines from Patent Expiries
GBI Research, the leading business intelligence provider, has released its latest research, ‘Gastrointestinal Therapeutics (Irritable Bowel Syndrome, Ulcerative Colitis and Crohn’s Disease) in Major Developed Markets’, which provides insights into three gastrointestinal therapeutic indications in the major developed markets of the US, the UK, France, Germany, Italy, Spain, Japan and Canada. The report provides an in-depth analysis of three gastrointestinal therapeutics markets, namely Irritable Bowel Syndrome (IBS), Ulcerative Colitis (UC) and Crohn’s Disease (CD). The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of th
Published Date: Jan 2014
Published By: GBI Research

Price: $3500
Frontier Pharma: Systemic Lupus Erythematosus - Identifying and Commercializing First-in-Class Innovation
The Systemic Lupus Erythematosus (SLE) drug market is currently under-served by non-generic, targeted therapies. Whilst the only Food and Drug Administration (FDA)-approved biologic, Benlysta (belimumab), generated sales of $111m in 2012, there is little evidence that the drug’s performance is significantly superior to other B-cell targeted therapies such as Rituxan (rituximab), which is often used off-license to treat refractory SLE patients. Therapeutics entering the market therefore do not face the staggering level of competition from currently marketed programs as in other markets such as the Rheumatoid Arthritis (RA) market. Emerging market entrants that appear to offer significant therapeutic benefits are likely to cause dramatic changes to the market landscape. A growing
Published Date: Dec 2013
Published By: GBI Research

Price: $3500
Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth
GBI Research has released the pharma report - “Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth” Gastric and esophageal cancers are two orphan cancers of the gastrointestinal tract. They are often diagnosed at advanced, incurable stages due to a late onset of symptoms, but are also associated with low survival rates in the early stages of disease. Currently the primary treatment options are chemotherapy and surgery, which are used wherever possible. One monoclonal Antibody (mAb), Herceptin (trastuzumab) is marketed for use in suitable patients with advanced gastric or gastro-esophageal junction cancer. However, the late-stage pipelines for these indications include man
Published Date: Dec 2013
Published By: GBI Research

Price: $3500
Parkinsons Disease Therapeutics Market to 2019 - Pipeline Shows Shift towards Long Term Disease Management
GBI Research has released the pharma report - “Parkinson’s Disease Therapeutics Market to 2019 - Pipeline Shows Shift towards Long Term Disease Management”. The Parkinson’s Disease (PD) market is dominated by symptomatic treatments targeting functional impairment in PD. Levodopa has remained the gold standard treatment for almost 40 years and has significantly improved patient quality of life. There is currently there is a huge unmet need for disease-modifying treatments that slow progression or have neuroprotective properties. Over the 2012–2019 forecast period, the PD market is anticipated to decline from $3.4 billion in 2012 to $2.9 billion in 2019, as a consequence of upcoming patent expirations of high-profile products such as Azilect, Stalevo and Comtan.
Published Date: Dec 2013
Published By: GBI Research

Price: $3500
Monoclonal Antibodies Market in Colorectal Cancer to 2019 - Favorable Pricing Policy in the US and Rising Prevalence in Europe and Japan Ensures Market Growth
GBI Research, has released the pharma report - “Monoclonal Antibodies Market in Colorectal Cancer to 2019 - Favorable Pricing Policy in the US and Rising Prevalence in Europe and Japan Ensures Market Growth”. There are currently three monoclonal Antibody (mAb) treatments approved for metastatic colorectal cancer with the purpose of extending the patient’s lifespan; Avastin, Erbitux and Vectibix. The current market leader is Avastin, which generated revenues of $6.2 billion in 2012 across a number of oncology indications. While compelling late-stage candidates are absent from the current pipeline, the anticipated rise in total prevalence of colorectal cancer in the top eight markets may inspire further investment. Pricing patterns for mAbs are highly favorable in the US, t
Published Date: Dec 2013
Published By: GBI Research

Price: $3500
Traditional Wound Management Market to 2019 - Cost Sensitivity Spurs Adoption in Emerging Markets, as Uptake of Advanced Wound Management Products Limits Growth in Developed Economies
GBI Research’s report Traditional Wound Management Market to 2019 looks at the market, key market players, and market dynamics for the global traditional wound management market. It provides a synopsis of the various factors influencing the market and its segments – bandages, gauzes and sponges. The report also gives company descriptions, lists the key marketed products for major market players and details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts. Scope Key geographies: the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil Information on market size for the
Published Date: Dec 2013
Published By: GBI Research

Price: $3500
Ophthalmology Therapeutics in Major Developed Markets to 2019 - New Drug Approvals and Promising Pipeline to Trigger Shift in Treatment Paradigm to Combination Therapies
GBI Research has released its pharma research, "Ophthalmology Therapeutics in Major Developed Markets to 2019 - New Drug Approvals and Promising Pipeline to Trigger Shift in Treatment Paradigm to Combination Therapies", which provides insights into two therapeutic indications in ophthalmology in Top Eight Markets of the US, the UK, France, Germany, Italy, Spain, Japan and Canada. The report provides an in-depth analysis of the therapeutic indications of ophthalmology, namely glaucoma and Dry Eye Syndrome (DES). The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these two ophthalmology indications. Scope
Published Date: Dec 2013
Published By: GBI Research

Price: $3500
Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 - Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat
GBI Research has released its pharmaceutical research, "Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 – Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat", which provides insights into three cardiovascular therapeutic indications in the top eight markets of the US, the UK, Germany, France, Italy, Spain, Japan and Canada. The report provides an in-depth analysis of the cardiovascular therapeutic indications, namely heart failure, myocardial infarction (MI), acute coronary syndrome (ACS). The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these three c
Published Date: Nov 2013
Published By: GBI Research

Price: $3500
Cardiovascular Diseases Therapeutics Market in Asia-Pacific to 2019 - Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion and Off-Label Use
GBI Research has released its pharmaceutical research, "Cardiovascular Diseases Therapeutics Market in Asia-Pacific to 2019 - Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion and Off-Label Use", which provides insights into three cardiovascular therapeutic indications in in Asia-Pacific (APAC) markets of India, China, Japan and Australia. The report provides an in-depth analysis of the cardiovascular therapeutic indications, namely heart failure, myocardial infarction (MI), acute coronary syndrome (ACS). The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these three cardiovascular indi
Published Date: Nov 2013
Published By: GBI Research

Price: $3500
Prostate Cancer Therapeutics Market to 2019 - Rising Prevalence and Strong Uptake of Recent Approvals to Drive Robust Growth to 2019
GBI Research has released the pharmaceutical report - “Prostate Cancer Therapeutics Market to 2019 - Rising Prevalence and Strong Uptake of Recent Approvals to Drive Robust Growth to 2019”. The recent approval of a number of highly effective drugs, including Zytiga and Xtandi, has provided late-stage patients with a number of options and increased survival times by a number of months. These recent approvals are anticipated to generate strong revenues during the forecast following increasing uptake by physicians as the treatment algorithm shifts towards their first-line usage over Taxotere. Additionally, a very large late-stage pipeline is anticipated to produce a number of new market entrants which are superior to existing products. Overall, this is anticipated to drive rapid
Published Date: Nov 2013
Published By: GBI Research

Price: $3500
Pressure Relief Devices Market to 2019 - Increasing Focus on Pressure Ulcer Prevention and Quality of Care to Drive Growth
GBI Research’s report: “Pressure Relief Devices Market to 2019” looks at the market, competitive landscape, and trends for the four pressure relief devices market segments: mattress overlays, specialty beds (rentals), specialty beds (sales), and mattresses. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment’s pipeline products and gives details of important Merger and Acquisition (M&A) deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Key geographies: the US,
Published Date: Nov 2013
Published By: GBI Research

Price: $3500
Macular Degeneration Therapeutics Market in Asia-Pacific to 2019 - Existing Angiogenics Retain Dominance Though High Unmet Need Remains
GBI Research has released its research, “ Macular Degeneration Therapeutics Market in Asia-Pacific to 2019 - Existing Angiogenics Retain Dominance Though High Unmet Need Remains”, which provides in-depth insights into the macular degeneration market forecast until 2019 for the Asia-Pacific (APAC) region covering the four countries of Australia, China, India and Japan. It also covers disease epidemiology; treatment algorithms; treatment patterns; an in-depth analysis of clinical trials including failure rate analysis, pipeline analysis; and an analysis of deals relevant to macular degeneration. Apart from these the report also includes a heat map for the macular degeneration marketed products.  GBI Research analysis shows that the APAC ophthalmology market for macular
Published Date: Oct 2013
Published By: GBI Research

Price: $3500
Alzheimers Disease Therapeutics Market to 2019 - Early Stage Innovation Points to Disease Modifying Therapies and Market Transformation
GBI Research has released its pharmaceuticals report: "Alzheimer’s Disease Therapeutics Market to 2019 - Early Stage Innovation Points to Disease Modifying Therapies and Market Transformation". The Alzheimer’s Disease (AD) market is characterized by a lack of products with strong disease-modifying properties and a number of high-profile product failures in late stages of development over recent years. In addition, recent or impending patent expiries for all of the four currently marketed products and a late-stage pipeline with limited-to-moderate prospects are expected to impede growth over the next few years.  In the medium-term future, the market is expected to be characterized by substantial generic competition and overall decline. However, the current developmen
Published Date: Oct 2013
Published By: GBI Research

Price: $3500
Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth
GBI Research has released the pharmaceutical report “Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth”. The current market for breast cancer consists of five monoclonal Antibodies (mAbs), three of which are targeted at the Human Epidermal growth factor Receptor 2 (HER-2) protein. Four are aimed at improving overall survival in the metastatic setting, and two of these have also received further approvals in the early setting in order to improve long-term remission rates.  The market is currently led by the HER-2 inhibitor Herceptin, which achieved global sales amounting to $6.2 billion in 2012. Over the forecast period from 2012 to 2019, the two novel HER-2 inhibitors, Kadcyla and Perjeta, ar
Published Date: Oct 2013
Published By: GBI Research

Price: $3500
Frontier Pharma - Rheumatoid Arthritis: Identifying and Commercializing First-in-Class Innovation
GBI Research has released a new pharmaceutical report, “Frontier Pharma: Rheumatoid Arthritis Identifying and Commercializing First-in-Class Innovation”. This highly competitive market is saturated with multiple targeted monoclonal Antibody (mAb) therapies and small molecules, yet more of these treatments are expected to enter the market over the next few years. Despite this, the current developmental pipeline is highly innovative beyond these me-too products and incremental innovations and promises a number of first-in-class products across all stages. These new developments are driven by improvements in the understanding of signaling pathways and underlying disease mechanisms of Rheumatoid Arthritis (RA). These highly innovative products are expected to increase the diver
Published Date: Oct 2013
Published By: GBI Research

Price: $3500
Type 2 Diabetes Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019
GBI Research has released its latest report for the pharmaceuticals industry, “Type 2 Diabetes Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019”. There is currently a large number of blood glucose-lowering drugs in the crowded type 2 diabetes market indicated for the treatment of chronically high blood glucose. The market is led by Lantus, which achieved global sales amounting to $6.4 billion in 2012. Over the forecast period from 2012 to 2019, the safer, more efficacious newer classes of drug (GLP-1 agonists, DPP-4 Inhibitors and SGLT-2 inhibitors) are expected to capture substantial market shares, largely replacing older classes such as sulfonylureas and thiazolidinediones. Additionally, a variety of novel drugs be
Published Date: Oct 2013
Published By: GBI Research

Price: $3500
Type 2 Diabetes Therapeutics Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019
GBI Research has released its latest report for the pharmaceuticals industry, “Type 2 Diabetes Therapeutics Market to 2019 A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019”. There is currently a large number of blood glucose-lowering drugs in the crowded type 2 diabetes market indicated for the treatment of chronically high blood glucose. The market is led by Lantus, which achieved global sales amounting to $6.4 billion in 2012. Over the forecast period from 2012 to 2019, the safer, more efficacious newer classes of drug (GLP-1 agonists, DPP-4 Inhibitors and SGLT-2 inhibitors) are expected to capture substantial market shares, largely replacing older classes such as sulfonylureas and thiazolidinediones. Additionally, a variety of nov
Published Date: Oct 2013
Published By: GBI Research

Price: $3500
Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth
GBI Research, a leading business intelligence provider, has released its latest research report “Asthma Market to 2019”. The asthma market is forecast to grow marginally over the forecast period across the leading eight developed nations, from $16.6 billion in 2012 to a projected value of $21.6 billion in 2019. This growth is expected despite the generic erosion facing the leading brands, and is a consequence of new market entrants and a disease prevalence that continues to rise, albeit not at rates as high as have been seen in the past. Some new, costly asthma therapies could be set to enter the asthma market, including GlaxoSmithKline’s (GSK’s) recently approved Relvar (fluticasone/vilanterol), and multiple monoclonal antibodies (mAbs).  These include re
Published Date: Oct 2013
Published By: GBI Research

Price: $3500
Mammography Equipment Market to 2019 - Growth Driven by Technical Advances in Digital Radiography that Enhance Workflow and Improve Breast Cancer Detection
GBI Research’s report: Mammography Equipment Market to 2019 – Growth Driven by Technical Advances in Digital Radiography that Enhance Workflow and Improve Breast Cancer Detection looks at the market, competitive landscape, and trends for the two mammography equipment market segments: digital radiography mammography equipment and film-screen mammography equipment. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment’s pipeline products and gives details of important Merger and Acquisition (M&A) deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-hous
Published Date: Oct 2013
Published By: GBI Research

Price: $3500
Computed Tomography Systems Market to 2019 - Lower Radiation Dose and Improved Workflow in Advanced CT Systems to Increase Adoption Rates
GBI Research’s report: “Computed Tomography Systems Market to 2019 – Lower Radiation Dose and Improved Workflow in Advanced CT Systems to Increase Adoption Rates” looks at the market, competitive landscape, and trends for three computed tomography systems segments: high slice computed tomography systems, mid slice computed tomography systems and low slice computed tomography systems. The report provides comprehensive information on the key trends affecting these segments and analyzes the market dynamics. It also reviews the competitive landscape and the details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts.
Published Date: Oct 2013
Published By: GBI Research

Price: $3500
Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies
GBI Research, the leading business intelligence provider, has released its latest research: Solid Tumors in Asia-Pacific Market to 2019 - New and Anticipated Approvals of Targeted Therapies to Trigger a Shift in Treatment Paradigm, which provides in-depth analysis of four key therapeutic indications within the Asia-Pacific (APAC) solid tumors market – bladder cancer, ovarian cancer, pancreatic cancer and prostate cancer – covering the four countries of Australia, China, India and Japan. The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these four solid tumor types.  The value of the soli
Published Date: Sep 2013
Published By: GBI Research

Price: $3500
Ostomy Drainage Bags Market to 2019 - Technical Advances Increase Patient Convenience but Unfavorable Reimbursement Scenarios Limit Growth Potential
GBI Research’s report: “Ostomy Drainage Bags Market to 2019 – Technical Advances Increase Patient Convenience but Unfavorable Reimbursement Scenarios Limit Growth Potential” looks at the market, key market players, and market dynamics for the global ostomy drainage bags market. It provides a synopsis of the various factors influencing this market. The report also gives company descriptions and lists the key marketed products for major market players. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope Key geographies: the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil Informatio
Published Date: Sep 2013
Published By: GBI Research

Price: $3500
Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
GBI Research, the leading business intelligence provider, has released its latest research: Obesity Therapeutics to 2019 – Safety Concerns Hinder Drug Performance Despite Large Market Opportunity”. Obesity is often described as a global endemic, with incidence dramatically increasing over the past decades, particularly in developed countries. Being overweight or obese is a major risk factor in the development of many chronic diseases, including cardiovascular diseases, cancer, and diabetes, of which treatment incurs extensive economic and healthcare costs.  Numerous anti-obesity drugs have been approved in the past decade, including Knoll Pharmaceutical’s Meridia (sibutramine) and Acomplia (rimonabant), only for them to be removed from the market due to evidence
Published Date: Aug 2013
Published By: GBI Research

Price: $3500
Compression Therapy Market to 2019 - Growth due to Increased Awareness in Venous Disease Management Offset by Reimbursement Issues
GBI Research’s report: “Compression Therapy Market to 2019 – Growth due to Increased Awareness in Venous Disease Management Offset by Reimbursement Issues” looks at the market, competitive landscape, and trends for the two compression therapy market segments: static compression therapy and dynamic compression therapy. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment’s pipeline products and gives details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts
Published Date: Aug 2013
Published By: GBI Research

Price: $3500
Cataract Surgery Devices Market to 2019 - Advanced Intraocular Lenses (IOLs) and a Growing Patient Population in Emerging Countries Offer Significant Growth Potential
GBI Research’s report: “Cataract Surgery Devices Market to 2019 – Increasing Cataract Prevalence due to Aging Population, Technical Advances in IOLs, and Shifting Companies’ Focus on Emerging Countries to Drive Future Growth” looks at the market, competitive landscape, and trends for the three cataract surgery devices market segments: intraocular lens (IOL), ophthalmic viscoelastic devices (OVD) and phacoemulsification equipment. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics.  The report also reviews the competitive landscape, analyzes each segment’s pipeline products and gives details of important M&A deals. It is built using data and information sourced
Published Date: Aug 2013
Published By: GBI Research

Price: $3500
Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth
GBI Research, the leading business intelligence provider, has released its latest research, “Multiple Sclerosis Therapeutics to 2019 Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth”. Currently there are a number of disease-modifying drugs in the Multiple Sclerosis (MS) market that are indicated for the treatment of relapsing forms of the disease, specifically reducing the frequency of disease relapses. The market is led by Copaxone, which achieved global sales of $4 billion in 2012. Over the forecast period 2012–2019, a variety of new drugs are due to enter the market that will offer a vast improvement in efficacy but also convenience, as many of these drugs are orally administered. Additionally, a high number of monoclonal
Published Date: Jul 2013
Published By: GBI Research

Price: $3500
Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline
GBI Research’s report “Pain Management Therapeutics Market to 2019 Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline“ provides insights and analysis into the market. Pain is a widespread problem across the world. More than 25% of the total population suffers from some clinically significant pain in a year. Since pain considerably affects day-to-day activities in life, its management presents a considerable challenge for physicians. Inadequate pain control remains a major problem across the world. There is an urgent and unmet need to manage these pain-related problems accurately. Currently, the management of pain is not efficient due to low diagnosis and prescription rates. In many cases, such as cancer pain, 5
Published Date: Jul 2013
Published By: GBI Research

Price: $3500
Purified Terephthalic Acid Global Market to 2020 - Overcapacity and Declining Margins to Hinder Global Demand in the Short Term
GBI Research’s ‘Purified Terephthalic Acid Global Market to 2020 – Overcapacity and Declining Margins to Hinder Global Demand in the Short Term’ is an in-depth report focusing on the demand side of the global Purified Terephthalic Acid (PTA) industry. The report provides the reader with detailed analysis and forecasts of the major economic and market trends expected to affect global PTA demand in all major regions of the world. It also provides analysis and description of the major drivers and restraints affecting PTA demand in various regions. Global PTA demand is assessed in terms of end-user segments, price, and competitive landscape, at both the regional and national level. Scope Drivers, restraints and challenges affecting the growth of the PTA mark
Published Date: Jul 2013
Published By: GBI Research

Price: $1000
Wound Closure Devices Market to 2019 - Increasing Sports-related Injuries Worldwide and Increasing Number of Road Accidents in Middle-Income Countries to Drive the Wound Closure Devices Market
GBI Research’s report: “Wound Closure Devices Market to 2019 – Increasing Sports-related Injuries Worldwide and Increasing Number of Road Accidents in Middle-Income Countries to Drive the Wound Closure Devices Market” looks at the market, competitive landscape, and trends for the five wound closure devices market segments: mechanical stapling devices, hemostats, tissue sealants, ligating clips, and wound closure strips. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment’s pipeline products and gives details of important M&A deals. It is built using data and information sourced from proprietary database
Published Date: Jul 2013
Published By: GBI Research

Price: $3500
Offshore Drilling Industry in Europe to 2016 - Norway a Driving Force for the European Offshore Drilling Industry, Reserves and Development Projects
GBI Research, a leading business intelligence provider, has released its latest research, “Offshore Drilling Industry in Europe to 2016 – Norway a Driving Force for the European Offshore Drilling Industry, Reserves and Development Projects”. The study, which is an offering from the company’s Energy Research Group, provides an in-depth analysis of the offshore drilling industry in Europe and highlights the various concerns, shifting trends and major happenings in regions worldwide. Scope Overview and analysis of the offshore drilling industry of Europe Analysis of the historical trends and forecasts to 2016 Analysis and forecasts of offshore wells drilled and offshore drilling expenditure Provides country-specific data analysis of Norway, Denmark, The
Published Date: Jul 2013
Published By: GBI Research

Price: $1000
Transcatheter Heart Valve Market Outlook, 2013 - Approval of Second Generation Prosthetics and Increasing Surgeons Confidence and Proficiency to Drive TAVR Procedure Volumes
GBI Research’s “Transcatheter Transcatheter Heart Valve Market Outlook, 2013 - Approval of Second Generation Prosthetics and Increasing Surgeons’ Confidence and Proficiency to Drive TAVR Procedure Volumes” report examines the market, competitive landscape, and trends for the Transcatheter Heart Valves (THVs) market. The report provides comprehensive information on the key trends affecting these segments, and key analytical content related to market dynamics. The report also reviews the competitive landscape and provides a detailed analysis of the pipeline products for each segment, as well as details of important Mergers and Acquisitions (M&A) deals. The report has been compiled using data and information sourced from proprietary databases, primary and seconda
Published Date: Jun 2013
Published By: GBI Research

Price: $3500